Nivolumab and ipilimumab combination treatment in patients with advanced uterine leiomyosarcoma: Results from the phase II MoST-CIRCUIT trial (ESMO Asia 2026) - Oct 1, 2026 - Abstract #475RO; Pres time: Dec 6, 2026; 09:33 AM - 09:38 AM; Location: Hall 405; No abstract available
Clinical • Metastases • P2 data • Leiomyosarcoma • Oncology • Sarcoma • Solid Tumor • Uterine Leiomyosarcoma
|
|
Oliver Klein; Matteo Carlino; Michael Michael; John Grady; Craig R. Underhill; Wei-sen Lam; Eliza Grills; Damien Kee; Robert Zielinski; Megan Lyle; Su A. Win; Anne Hamilton; Yoland Antill; Nabilah Zulkifli; Jodie B. Palmer; Jessica Duarte; David Thomas; Kylie Wilkie; Jonathan Cebon; Bo Gao
|